 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 54
|
|
-
Commission procrastinates on GMOs while millions of farmers worldwide are growing them
(09 May 2008)
The EU Commission held a debate on the biotech crop approval process in Europe and sent out a disappointing signal when it agreed to send back three cultivation dossiers which had been positively assessed. Europe is already lagging behind ......
-
European biotech industry sets the record straight on biofuels and outlines contribution of biotech to a low-carbon society
(17 Mar 2008)
At a press briefing held at World Biofuels Markets in Brussels, the biotech industry set the record straight on biofuels and showed how biotechnology can contribute to a low-carbon society by helping to deliver sustainable, secure and ......
-
SMEs are THE new paradigm for innovation in healthcare
(06 Mar 2008)
EuropaBio championed the innovative role that Small and Medium-sized Enterprises (SMEs) have the potential to play in the European economy at the Drug Information Association's 20th EuroMeeting 3-5 March in Barcelona. Academics, policy makers ......
-
Biotech industry supports common security market for Bio-Preparedness
(19 Feb 2008)
EuropaBio, the European Association for Bio-Industries, welcomes the conclusions from the STACCATO workshop on Bio-Preparedness. Approximately 100 experts in the field of bio-safety and bio-security met with the European Commission DG Health ......
-
Minister predicts role for stem cell biologist in re-shaped pharmaceutical industry
(17 Jan 2008)
Stem cell research should have a bright future and could play an important role in tomorrow's pharmaceutical industry, Spain's Minister for Health told an international conference of stem cell biologists on January 11. Professor Bernat Soria, ......
-
French biotech crop decision environmentally unfriendly
(16 Jan 2008)
According to EuropaBio, the French Government's decision to invoke the safeguard clause on biotech maize contradicts the conclusions of the French Environment Round Table (Grenelle de l'Environnement) and government policy on ecological and ......
-
BIO Commemorates the 25th Anniversary of the Orphan Drug Act
(08 Jan 2008)
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement commemorating the 25th anniversary of the Orphan Drug Act. This landmark law helped lead to the development of new drugs and biologics for ......
-
European Court of Justice to rule on Lithuania's failure to abide by European law on biosimilars
(11 Dec 2007)
EuropaBio - the EU association for bioindustries - welcomes the European Commission's action against Lithuania in the European Court of Justice on the grounds that a biosimilar product placed on the Lithuanian market does not meet the ......
-
Portuguese Presidency promotes the EU's commitment to healthcare biotechnology
(23 Nov 2007)
EuropaBio congratulates the Portuguese Presidency and Infarmed, the Portuguese national authority of medicines and health products, for their initiative to focus on innovation's benefits for patients at the conference 'Pharmaceutical ......
-
Misuse of cost containment policies threatens patient access to Orphan Medicines
(23 Oct 2007)
EuropaBio welcomed the 8th EPPOSI Workshop on Partnering for Rare Disease Therapy Development in Copenhagen (Denmark) on 18-19 October. Organised by the European Platform for Patients' Organisations, Science & Industry (EPPOSI), the workshop ......
|
|
|
Top